Oshi Health, Inc. – Trademark Portfolio
Entity Type: 03
Oshi Health, Inc. has 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include OSHI HEALTH. The portfolio includes 1 registered trademark. Filings span 4 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 44 (Medical Services). This trademark owner is based in New York, NY.
10 Hudson Yards, 46th Floor
New York, NY 10001
Showing of trademarks Trademarks
Trademark Classifications
Oshi Health, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Oshi Health, Inc. have?
Oshi Health, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 3 cancelled.
What trademark classes does Oshi Health, Inc. file in?
Oshi Health, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Oshi Health, Inc.'s most well-known trademarks?
Oshi Health, Inc.'s registered trademark portfolio includes well-known marks such as OSHI HEALTH. These are among 1 currently registered trademark in the portfolio.
What is Oshi Health, Inc.'s trademark registration success rate?
Oshi Health, Inc. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.